Lv5
820 积分 2023-12-12 加入
Glucagon-like peptide-1 receptor agonists for obesity: Growing popularity met with growing questions over safety
6天前
已完结
Cirrhotic portal vein thrombosis as a vascular rather than a thrombotic disorder
9天前
已关闭
Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis
10天前
已完结
Glutathione kinetics in normal man and in patients with liver cirrhosis
15天前
已完结
Defective Methionine Metabolism in Cirrhosis: Relation to Severity of Liver Disease
15天前
已完结
Dying for a cause: NETosis, mechanisms behind an antimicrobial cell death modality
15天前
已完结
Endothelial-to-mesenchymal transition: A targetable mechanism that contributes to portal vein thrombosis in cirrhosis
17天前
已完结
Treatment of portal vein thrombosis in cirrhosis is associated with no survival advantage: a retrospective controlled study
18天前
已完结
The effect of splenic vein diameter on the diagnosis of portal vein thrombosis
18天前
已完结
Left Lobe Living Donor Liver Transplantation Using Rapid Procedure in a Cirrhotic Patient With Portal Vein Thrombosis
19天前
已关闭
皖公网安备34019202002308
